Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

November 12, 2019

Study Completion Date

November 12, 2019

Conditions
Tourette Syndrome
Interventions
DRUG

TEV-50717

6, 9, 12, 15, and 18 mg oral tablets

DRUG

Placebo

Placebo matched to TEV-50717 tablets will be taken BID for 12 weeks.

Trial Locations (42)

2730

Teva Investigational Site 046-0302, Herlev

5000

Teva Investigational Site 046-0301, Odense

10029

Teva Investigational Site 046-0124, New York

11000

Teva Investigational Site 046-1702, Belgrade

Teva Investigational Site 046-1703, Belgrade

14618

Teva Investigational Site 046-0102, Rochester

14642

Teva Investigational Site 046-0112, Rochester

21000

Teva Investigational Site 046-1701, Novi Sad

23805

Teva Investigational Site 046-0118, Petersburg

27607

Teva Investigational Site 046-0125, Raleigh

28009

Teva Investigational Site 046-0605, Madrid

28922

Teva Investigational Site 046-0602, Madrid

29620

Teva Investigational Site 046-0603, Málaga

30331

Teva Investigational Site 046-0116, Atlanta

32803

Teva Investigational Site 046-0115, Orlando

33155

Teva Investigational Site 046-0132, Miami

33701

Teva Investigational Site 046-0114, St. Petersburg

36303

Teva Investigational Site 046-0104, Dothan

41013

Teva Investigational Site 046-0601, Seville

60563

Teva Investigational Site 046-0133, Naperville

63304

Teva Investigational Site 046-0110, Saint Charles

72758

Teva Investigational Site 046-0107, Rogers

73116

Teva Investigational Site 046-0106, Oklahoma City

75243

Teva Investigational Site 046-0113, Dallas

77030

Teva Investigational Site 046-0108, Houston

77090

Teva Investigational Site 046-0103, Houston

78249

Teva Investigational Site 046-0120, San Antonio

84058

Teva Investigational Site 046-0105, Orem

85351

Teva Investigational Site 046-0117, Sun City

92108

Teva Investigational Site 046-0111, San Diego

92705

Teva Investigational Site 046-0130, Santa Ana

92805

Teva Investigational Site 046-0126, Anaheim

95815

Teva Investigational Site 046-0101, Sacramento

355038

Teva Investigational Site 046-0702, Stavropol

394024

Teva Investigational Site 046-0703, Voronezh

634050

Teva Investigational Site 046-0704, Tomsk

02114

Teva Investigational Site 046-0128, Boston

68526-9467

Teva Investigational Site 046-0134, Lincoln

08043

Teva Investigational Site 046-0109, Voorhees Township

L1Z0M1

Teva Investigational Site 046-0201, Ajax

K2G 1W2

Teva Investigational Site 046-0202, Ottawa

08041

Teva Investigational Site 046-0604, Barcelona

Sponsors
All Listed Sponsors
collaborator

Nuvelution TS Pharma, Inc.

INDUSTRY

lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY